Ventures · Hospital Granja Julieta
Hospital Granja Julieta: what it is and why it matters
Hospital Granja Julieta, in São Paulo, is a clinical partner of Xperienc, founded by Bairo Gonzalez. He is neither a partner nor a founder of the hospital.
Hospital Granja Julieta is a hospital in São Paulo, a separate company with its own shareholders, that acts as a clinical partner of Xperienc Global Labs, the company founded by Bairo Leandro Gonzalez Martinez; Bairo is not a shareholder, founder or administrator of the hospital.
The pain behind it
This page exists because the question comes up: what is Bairo's relationship with the hospital? The honest answer begins with a lesson he learned by falling.
Bairo lost businesses because they rested on promises, not on solid ground. An investment that was not what it seemed, partners who took the idea, a project that collapsed when the people he was helping walked away. Every fall left the same conclusion: an idea without a physical place does not stand.
When Xperienc was born, he knew that a health platform made only of software would be one more promise. Science needs a place where people are observed, records are kept and professionals are trained. The meeting with Hospital Granja Julieta gave Xperienc that place. On the hospital's side, the pain was different, and very concrete: medical cannabis is growing in Brazil almost entirely outside the hospital setting, far from anyone who can observe the person calmly.
How it works, in plain words
These are two companies, with different roles.
- The hospital is the place of care. It has its own clinical staff, technical leads and protocols, and it answers for every medical decision. It is a general hospital with surgical facilities, with head and neck surgery as its anchor specialty. It has no emergency room: in an emergency, the way is SAMU, Brazil's ambulance service, at 192, or the nearest urgent care service.
- Xperienc is the partner for technology, research and international connection. It brings the hospital the design of the triage system with a clinical assistant and human validation, teleconsultation, the Global Language translator and the bridge to specialists from other countries.
The partnership plans a wing with cannabinoid protocols under medical supervision, a laboratory for studies and analysis, and a training center for professionals. The idea guiding it all is to treat cannabis as one of medicine's tools, assessed case by case, never as the basis for everything nor as a promise.
Who it is for
- Patients who, with a medical indication, want to be followed in a hospital setting, with observation and records.
- Doctors who want to refer or discuss cases with a team that brings together conventional and cannabinoid medicine.
- Health professionals seeking serious training on cannabinoids.
- Researchers and patient associations interested in recorded outcomes.
Clinical matters are handled directly with the hospital, through its official channels. This site does not book appointments or give treatment advice.
The market
In 2025, 873,000 Brazilians used cannabis-based products, 30% more than the year before. Access, according to the same survey, was split between imports (40%), pharmacies (34%) and patient associations (26%), and 59% of cities recorded at least one dispensation (Kaya Mind, 2025 Yearbook). That is a lot of people, almost all of them treated away from a hospital bed.
The rules have changed too. In 2026, Anvisa published a new framework for cannabis products, in force since May, which revoked RDC 327/2019 and redesigned manufacturing, prescription and dispensing (Anvisa). Clearer rules call for more clinical supervision and more traceability.
And the science is still at an early stage. The 2017 review by the U.S. National Academies found conclusive or substantial evidence for a few conditions, and limited or insufficient evidence for most others (NASEM, 2017). That is exactly where a hospital that records outcomes can contribute.
Where it stands today
What is on the public record: Hospital Granja Julieta Ltda, CNPJ 44.806.422/0001-24, in São Paulo, with its own shareholders, among whom Bairo is not listed. The website hospitalgranjajulieta.com.br is live.
Teleconsultation and second opinions are still being set up, as is the integration with Xperienc's technology. The hospital does not speak of success rates, and neither does this site: what is described is conduct, never a promised result.
Why it scales and why it matters
A hospital does not replicate like an app. What replicates is knowledge: written protocols, training of professionals, teleconsultation and consultation between doctors. A doctor trained here takes the method back to their own city. A well-documented protocol can be studied in any country.
For the ecosystem, the partner hospital plays a role no software replaces. It is the physical backing of the health front: the place where Xperienc's technology meets real patients, under the responsibility of people with the training and registration to provide care.
Why does it matter? Because medical cannabis is coming out of informality, and someone needs to receive it with rigor: assessment before prescription, observation during, records afterward, and referral to the right specialty when the evidence says the path lies elsewhere.
Bairo's role
Bairo does not own Hospital Granja Julieta. His role goes through Xperienc Global Labs, which he founded and runs: the vision of bringing technology, science and medical cannabis together into a single journey is his, and the contribution of technology, research and connection with specialists from other countries comes from Xperienc.
Clinical decisions belong to the hospital. Bairo insists on that separation, because it protects the patient and protects the truth about who answers for what.